Authors
Latest:
Choosing Personal Protective Equipment for Handling Cytotoxic DrugsCompanies manufacturing cytotoxic drugs must ensure that staff are given the highest possible levels of protection.
Latest:
Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk AssessmentIn-silico design facilitates process optimization and evaluation of process control strategies.
Latest:
Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk AssessmentIn-silico design facilitates process optimization and evaluation of process control strategies.
Latest:
Regulatory Considerations for Controlled Correspondence Related to Generic Drug ChemistryAn analysis of controlled correspondence between generic-drug manufacturers and FDA reveals patterns in questions about specific drug chemistry topics and the response to information provided in FDA guidance documents.
Latest:
Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk AssessmentIn-silico design facilitates process optimization and evaluation of process control strategies.
Latest:
Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk AssessmentIn-silico design facilitates process optimization and evaluation of process control strategies.
Latest:
Parenteral Formulation: Deciding When to Go Frozen or Freeze-DriedScientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.
Latest:
Process Validation of Legacy ProductThe authors outline a validation approach for the manufacture of a “legacy product,” taking into consideration recent guidelines. The aim is to demonstrate the validity and capacity of the manufacturing process following a change in the manufacturer.
Latest:
Process Validation of Legacy ProductThe authors outline a validation approach for the manufacture of a “legacy product,” taking into consideration recent guidelines. The aim is to demonstrate the validity and capacity of the manufacturing process following a change in the manufacturer.
Latest:
Process Validation of Legacy ProductThe authors outline a validation approach for the manufacture of a “legacy product,” taking into consideration recent guidelines. The aim is to demonstrate the validity and capacity of the manufacturing process following a change in the manufacturer.
Latest:
Standardizing Data ManagementIndustry players form Allotrope Foundation to solve analytical data management problems.
Latest:
Standardizing Data ManagementIndustry players form Allotrope Foundation to solve analytical data management problems.
Latest:
Cliffhanger"The patent expiry of several major blockbuster drugs worth $150 billion between 2010 and 2017 will fuel the growth of the global generic pharmaceuticals market," so says a press release announcing new analysis from Frost & Sullivan.
Latest:
Assessing and Improving the Palatability of PharmaceuticalsTaste may be subjective, but it is crucial to patient compliance, particularly for pediatric treatments.
Latest:
Assessing and Improving the Palatability of PharmaceuticalsTaste may be subjective, but it is crucial to patient compliance, particularly for pediatric treatments.
Latest:
Analytical Techniques for Oral Solid Dosage FormulationAnalytical technologies must accurately identify and measure the critical material attributes of APIs and excipients.
Latest:
Using Polymers for More Efficient Hot-Melt Extrusion and Spray DryingNew cellulosic polymers have been shown to improve solubility in these key amorphous solid dispersion processes.
Latest:
Rapid Screening for Elemental Impurities using ICP-MSThe authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.
Latest:
Validation of a Multiplex Bead-Based AssayThe authors present a validation study of an analytical method for the simultaneous determination of nine human cytokines in human K2-EDTA plasma.
Latest:
Keeping Up with Biologics AdvancesThe European Pharmacopoeia addresses the need for monographs for biologicals to keep pace with recent analytical technology advances.
Latest:
Best Practice: Developing Drugs that are Highly PotentHighly potent or cytotoxic drugs require special handling
Latest:
Developing an Orally Inhaled Dry Powder Formulation—A Complex Itinerary and a Technological ChallengeSuccessful drug delivery via a dry powder inhaler is determined by the API physicochemical properties, the formulation composition and process, the device and operating conditions, the patient–device relationship, the environmental variables, and ultimately, patient compliance.
Latest:
Breaking Down Pharma BordersWith the Indian pharmaceutical industry on the rise, manufacturing businesses are working together with European and American partners to harness their longstanding experience and reputation in cleanroom manufacturing for a broader pharmaceutical manufacturing marketplace.
